(R)-6-(2-Hydroxy-3-(4-(4-(trifluoromethyl)phenyl)piperazin-1-yl)propoxy)-3,4-dihydroquinolin-2(1H)-one

Catalog No. :
ACDTQJ762
CAS No. :
2914889-88-4
Molecular Formula :
C23H26F3N3O3
Molecular Weight :
449.47

IUPAC Name:(R)-6-(2-hydroxy-3-(4-(4-(trifluoromethyl)phenyl)piperazin-1-yl)propoxy)-3,4-dihydroquinolin-2(1H)-one

(R)-6-(2-Hydroxy-3-(4-(4-(trifluoromethyl)phenyl)piperazin-1-yl)propoxy)-3,4-dihydroquinolin-2(1H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-6-(2-Hydroxy-3-(4-(4-(trifluoromethyl)phenyl)piperazin-1-yl)propoxy)-3,4-dihydroquinolin-2(1H)-one
IUPAC Name(R)-6-(2-hydroxy-3-(4-(4-(trifluoromethyl)phenyl)piperazin-1-yl)propoxy)-3,4-dihydroquinolin-2(1H)-one
MDL No.MFCD35065452
Molecular FormulaC23H26F3N3O3
Molecular Weight449.47
SMILESO=C1NC2=C(C=C(OC[C@H](O)CN3CCN(C4=CC=C(C(F)(F)F)C=C4)CC3)C=C2)CC1
InChI KeyQJKYLYXHWSCZQT-LJQANCHMSA-N
SynonymNP10679;2(1H)-Quinolinone, 3,4-dihydro-6-[(2R)-2-hydroxy-3-[4-[4-(trifluoromethyl)phenyl]-1-piperazinyl]propoxy]-
CAS No.2914889-88-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACDTQJ762 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDTQJ762 route product structure diagram
    ACDTQJ7622914889-88-4
Inquiry

2. ACDTQJ762 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDTQJ762 route product structure diagram
    ACDTQJ7622914889-88-4
Inquiry

Comments (0)